176 related articles for article (PubMed ID: 15500127)
21. Focal segmental glomerulosclerosis and renal transplantation.
Crosson JT
Transplant Proc; 2007 Apr; 39(3):737-43. PubMed ID: 17445586
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and mutational survey of NPHS2 (podocin) in Japanese children with focal segmental glomerulosclerosis who underwent renal transplantation.
Furue T; Hattori M; Tsukaguchi H; Kitamura A; Oomori T; Ogino D; Nakakura H; Ashida A; Miura K; Hisano M; Takahashi K; Chikamoto H; Akioka Y; Sakano T
Pediatr Transplant; 2008 May; 12(3):341-6. PubMed ID: 18208440
[TBL] [Abstract][Full Text] [Related]
23. [Focal segmental glomerulosclerosis: Pathogenesis, pathophysiology, and therapy].
Hirayama K; Hagiwara M; Yamagata K; Koyama A
Nihon Rinsho; 2006 Feb; 64 Suppl 2():422-6. PubMed ID: 16523926
[No Abstract] [Full Text] [Related]
24. Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis.
Kerjaschki D
J Clin Invest; 2001 Dec; 108(11):1583-7. PubMed ID: 11733553
[No Abstract] [Full Text] [Related]
25. Focal segmental glomerulosclerosis: recent advances.
Pollak MR
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):138-42. PubMed ID: 18277145
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients.
Canaud G; Martinez F; Noël LH; Mamzer MF; Niaudet P; Legendre C
Transplant Rev (Orlando); 2010 Jul; 24(3):121-8. PubMed ID: 20537521
[TBL] [Abstract][Full Text] [Related]
27. Focal segmental glomerulosclerosis: molecular genetics and targeted therapies.
Chen YM; Liapis H
BMC Nephrol; 2015 Jul; 16():101. PubMed ID: 26156092
[TBL] [Abstract][Full Text] [Related]
28. Podocin-related mechanisms in posttransplant [corrected] recurrence of focal segmental glomerulosclerosis [corrected].
Caridi G; Dagnino M; Sanna-Cherchi S; Perfumo F; Ghiggeri GM
Transplant Proc; 2006 Dec; 38(10):3486-90. PubMed ID: 17175312
[TBL] [Abstract][Full Text] [Related]
29. [Nephrotic syndrome in childhood].
Reusz G; Szabó A; Fekete A
Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687
[TBL] [Abstract][Full Text] [Related]
30. Collapsing glomerulopathy.
Schwimmer JA; Markowitz GS; Valeri A; Appel GB
Semin Nephrol; 2003 Mar; 23(2):209-18. PubMed ID: 12704581
[TBL] [Abstract][Full Text] [Related]
31. Idiopathic focal segmental glomerulosclerosis.
Schnaper HW
Semin Nephrol; 2003 Mar; 23(2):183-93. PubMed ID: 12704578
[TBL] [Abstract][Full Text] [Related]
32. Treatment of focal segmental glomerulosclerosis.
Matalon A; Valeri A; Appel GB
Semin Nephrol; 2000 May; 20(3):309-17. PubMed ID: 10855941
[TBL] [Abstract][Full Text] [Related]
33. Review on diagnosis and treatment of focal segmental glomerulosclerosis.
Deegens JK; Steenbergen EJ; Wetzels JF
Neth J Med; 2008 Jan; 66(1):3-12. PubMed ID: 18219061
[TBL] [Abstract][Full Text] [Related]
34. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.
Kaplan JM; Kim SH; North KN; Rennke H; Correia LA; Tong HQ; Mathis BJ; Rodríguez-Pérez JC; Allen PG; Beggs AH; Pollak MR
Nat Genet; 2000 Mar; 24(3):251-6. PubMed ID: 10700177
[TBL] [Abstract][Full Text] [Related]
35. Genetics of focal segmental glomerulosclerosis.
Woroniecki RP; Kopp JB
Pediatr Nephrol; 2007 May; 22(5):638-44. PubMed ID: 17347836
[TBL] [Abstract][Full Text] [Related]
36. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4.
Michaud JL; Lemieux LI; Dubé M; Vanderhyden BC; Robertson SJ; Kennedy CR
J Am Soc Nephrol; 2003 May; 14(5):1200-11. PubMed ID: 12707390
[TBL] [Abstract][Full Text] [Related]
37. Effects of cyclosporine, azathioprine and prednisone on Kimura's disease and focal segmental glomerulosclerosis in renal transplant patients.
Senel MF; Van Buren CT; Etheridge WB; Barcenas C; Jammal C; Kahan BD
Clin Nephrol; 1996 Jan; 45(1):18-21. PubMed ID: 8616952
[TBL] [Abstract][Full Text] [Related]
38. A case report of plasmapheresis and cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis: recovery of renal function after five months on dialysis.
Oliveira L; Wang D; McCormick BB
Ther Apher Dial; 2007 Jun; 11(3):227-31. PubMed ID: 17498006
[TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical analysis of podocytopathy with immature glomeruli and glomerulosclerosis in children with nephrotic syndrome].
Ostalska-Nowicka D; Zachwieja J; Nowicki M; Siwińska A; Woźniak A
Przegl Lek; 2006; 63 Suppl 3():97-100. PubMed ID: 16898501
[TBL] [Abstract][Full Text] [Related]
40. Bigenic mouse models of focal segmental glomerulosclerosis involving pairwise interaction of CD2AP, Fyn, and synaptopodin.
Huber TB; Kwoh C; Wu H; Asanuma K; Gödel M; Hartleben B; Blumer KJ; Miner JH; Mundel P; Shaw AS
J Clin Invest; 2006 May; 116(5):1337-45. PubMed ID: 16628251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
